Investors

Founded in 1999 and listed on the Australian Securities Exchange in 2004, Cogstate (ASX.CGS) is a diversified business leading the field of cognitive testing.

Cogstate is a world-class science, services and technology company dedicated to measuring cognition to guide decision-making in clinical trials, research, healthcare and brain injury. From validated computerised batteries to expert support for traditional paper-and-pencil tests, science, innovation and excellence in delivery are at the core of everything we do.

Cogstate Highlights

  • Cogstate’s easy-to-use, computerised cognitive testing is based on science which has been widely accepted and validated both academically and commercially through hundreds of peer-reviewed publications
  • Cogstate solutions serve four distinct markets: Clinical Trials, Healthcare, Academic Research and Brain Injury
  • Cogstate has a history of strong financial performance with the Clinical Trials business enabling the company to self-fund R&D and commercialisation opportunities
  • Cogstate leverages its leading expertise in cognitive testing to penetrate growing markets in Healthcare and Brain Injury

Information for current and prospective Cogstate investors can be found in this section of our website, or you can contact our investor relations team at Buchan Consulting to request further information or arrange a meeting with the company.

Shareholder Services

The Cogstate Ltd share registry is maintained by Link Market Services Ltd. Shareholders can visit the Link Market Services Investor Centre to access information about shareholding and update details online. For security, shareholders will be asked to provide Securityholder Reference Number (SRN) or Holder Identification Number (HIN), surname and postcode.

Cogstate Investor Contact

Kyahn Williamson – Buchan Consulting
PHONE: +61 3 9866 4722
EMAIL: kwilliamson@buchanwe.com.au

Subscribe for Investor Updates

  • This field is for validation purposes and should be left unchanged.